Your browser doesn't support javascript.
loading
Therapeutic Approaches for Treating Pulmonary Arterial Hypertension by Correcting Imbalanced TGF-ß Superfamily Signaling.
Andre, Patrick; Joshi, Sachindra R; Briscoe, Steven D; Alexander, Mark J; Li, Gang; Kumar, Ravindra.
Affiliation
  • Andre P; Discovery Group, Acceleron Pharma (a wholly-owned subsidiary of Merck & Co., Inc.), Cambridge, MA, United States.
  • Joshi SR; Discovery Group, Acceleron Pharma (a wholly-owned subsidiary of Merck & Co., Inc.), Cambridge, MA, United States.
  • Briscoe SD; Discovery Group, Acceleron Pharma (a wholly-owned subsidiary of Merck & Co., Inc.), Cambridge, MA, United States.
  • Alexander MJ; Discovery Group, Acceleron Pharma (a wholly-owned subsidiary of Merck & Co., Inc.), Cambridge, MA, United States.
  • Li G; Discovery Group, Acceleron Pharma (a wholly-owned subsidiary of Merck & Co., Inc.), Cambridge, MA, United States.
  • Kumar R; Discovery Group, Acceleron Pharma (a wholly-owned subsidiary of Merck & Co., Inc.), Cambridge, MA, United States.
Front Med (Lausanne) ; 8: 814222, 2021.
Article in En | MEDLINE | ID: mdl-35141256
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Med (Lausanne) Year: 2021 Document type: Article Affiliation country: United States Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Med (Lausanne) Year: 2021 Document type: Article Affiliation country: United States Country of publication: Switzerland